InspireMD, Inc. (FRA:II2)

Market Cap	64.59M -17.7%
Revenue (ttm)	7.65M +28.1%
Net Income	-41.55M
EPS	-0.65
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,712
Average Volume	n/a
Open	1.640
Previous Close	1.430
Day's Range	1.640 - 1.640
52-Week Range	1.250 - 2.500
Beta	n/a
RSI	51.78
Earnings Date	Mar 18, 2026

About InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection syste...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 127
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: II2

Financial Performance

In 2025, InspireMD's revenue was $8.98 million, an increase of 28.11% compared to the previous year's $7.01 million. Losses were -$48.79 million, 52.4% more than in 2024.

Financial numbers in USD